Clearmind Medicine Inc.
Clearmind Medicine Inc. (CMND): 1 pipeline candidate · ~14 mo cash runway · 1 clinical trial. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
14.1 months
D/E 0.35
Lead: Phase 1/Phase 2
1 candidate
N/A
N/A
A transparent, data-derived signal for Clearmind Medicine Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$4.7M
Cash
$9.3M
Quarterly Burn
$2.1M
Runway
14.1 mo
Revenue
—
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (1 candidate)
| Drug | Phase |
|---|---|
| cmnd-100 | Phase 1/Phase 2 |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
5
Total value held
$30K
| Holder | Shares | Value |
|---|---|---|
| xtx topco ltd | 21,694 | $23K |
| advisorshares investments llc | 7,357 | $8K |
| hrt financial lp | 15,910 | $16 |
| ubs group ag | 1 | $1 |
| royal bank of canada | 14 | $0 |
Frequently asked questions
How many drug candidates are in Clearmind Medicine Inc.'s pipeline?
Clearmind Medicine Inc. (CMND) has 1 pipeline candidate tracked by BioSniper across SEC filings and clinical trial registrations.
What is Clearmind Medicine Inc.'s lead drug candidate?
Clearmind Medicine Inc.'s most advanced tracked candidate is cmnd-100 (Phase 1/Phase 2) for Alcohol Use Disorder.
What is Clearmind Medicine Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Clearmind Medicine Inc. has approximately 14.1 months of cash runway.
What is Clearmind Medicine Inc.'s market capitalization?
Clearmind Medicine Inc.'s market capitalization is approximately $4.7M.
Who is the CEO of Clearmind Medicine Inc.?
Dr. Adi Zuloff-Shani Ph.D. is the chief executive officer of Clearmind Medicine Inc. (CMND).
Get the full picture on Clearmind Medicine Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.